Neha Patil (Editor)

Loghman Pharmaceuticals

Updated on
Edit
Like
Comment
Share on FacebookTweet on TwitterShare on LinkedInShare on Reddit
Type
  
Public

Net income
  
44 Billion IRR (2009)

Founded
  
1968

Industry
  
Pharmaceutical

Headquarters
  
Tehran

Traded as
  
TSE: DLGM1 ISIN: IRO1DLGM0000

Key people
  
Khosro Davari, chief executive officer Alireza Zohrevand, Chairman

Products
  
Pharmaceutical drug Ampoule, Tablet (pharmacy), Capsule (pharmacy)

Loghman Pharmaceutical & Hygienic Co. (Persian: شرکت دارویی و بهداشتی لقمان‎‎) is an Iranian pharmaceuticals company. The company engages in the discovery, development, manufacture, and marketing of health care solutions in Iran.

Contents

History

Loghmans was established in 1968 as I.D.I. Pharmaceuticals. In 1979, the company changed its name to Loghman and expanded its operations.

The company has been listed on the Tehran Stock Exchange since 1997.

products

  • Acetaminophen+Codeine
  • Amoxicillin
  • Azithromycin
  • Buspirone
  • Carbamazepine
  • Cefalexin
  • Cefazolin
  • Cefepime
  • Cefixime
  • Ceftazidime
  • Ceftriaxone
  • Cefuroxime
  • Cefalexin
  • Diazepam
  • Erythromycin
  • Fluconazole
  • Sodium Fluoride
  • Ibuprofen
  • Indomethacin
  • Lorazepam
  • Losartan Potassium
  • Meropenem
  • Methimazole
  • Nortriptyline
  • Phenytoin
  • Sodium Fluoride
  • Sorbitol
  • Valsartan

    • Development plan

  • Insulin

    • References

    Loghman Pharmaceuticals Wikipedia
    (Text) CC BY-SA